Acetaminophen Blunts Antitumor Activity of Immunotherapy

(MedPage Today) -- Patients starting cancer immunotherapy with detectable levels of acetaminophen had worse outcomes, including response rate, progression-free survival (PFS), and overall survival (OS), in data from three patient cohorts.
In the...